Pharmaceutical Management Agency

Immunosuppressed/diabetic/cancer populations - common associated conditions.

Response by Pharmaceutical Management Agency to J Bruning on April 18, 2024.

Awaiting response.

Kia ora Jodie Thank you for your request for information, received by Pharmac on 17 April 2024. Your request has been received and logged. Our referen...

Homonal treatment data

Response by Pharmaceutical Management Agency to Simon Tegg on April 02, 2024.

Awaiting response.

Kia ora Simon Thank you for your request for information, received by Pharmac on 1 April 2024. Your request has been received and logged. Our referenc...

Decision not to provide information to Today FM or Mediaworks

Response by Pharmaceutical Management Agency to New Zealand Council for Civil Liberties on February 21, 2023.

Refused.

Tēnā koe Further to our previous communications, we have now published [1]information about our communications approach for the Trikafta consul...

GnRH Agonist statistics

Response by Pharmaceutical Management Agency to Simon Tegg on March 01, 2024.

Successful.

Kia ora Simon Please find a response to your request attached to this email. Ngâ mihi, Katy Carlson (she/her) | Government Services Advisor _______...

Pfizer Contractual Agreement

Response by Pharmaceutical Management Agency to Chuck Schooner (Account suspended) on January 19, 2022.

Long overdue.

Kia ora Chuck Please find a letter in response to your request attached with this email. Ngā mihi Melody Willis ([1]she/her) | Go...

Meeting with New Minister

Response by Pharmaceutical Management Agency to T Murray on January 26, 2024.

Successful.

Kia ora T Murray Please find a response to your request attached to this email. Ngâ mihi, Katy Carlson (she/her) | Government Services Advisor ____...

Maori staff retention

Response by Pharmaceutical Management Agency to TR on June 16, 2023.

Successful.

Tçnâ koe Please find a response to your request for information attached. Ngâ mihi, nâ Melody Willis (she/her) | Government Services Advisor ______...

Meeting with New Minister for Pharmac

Response by Pharmaceutical Management Agency to T Murray on December 12, 2023.

Refused.

Kia ora T Murray Please find a response to your request attached to this email. Ngâ mihi, Katy Carlson (she/her) | Government Services Advisor ____...

MoH criteria for Special Authority application of stimulant medication

Response by Pharmaceutical Management Agency to Cody C on December 11, 2023.

Information not held.

Kia ora Cody Please find a response to your request attached to this email. Ngâ mihi, Katy Carlson (she/her) | Government Services Advisor ________...

OIA publication

Response by Pharmaceutical Management Agency to Rex Davey on November 22, 2023.

Awaiting classification.

Kia ora Rex, Please find a response to your OIA request attached. Ngā mihi Pharmac Government Services Team 22 November 2023 Rex Davey Via email:...

Covid19 XBB Vaccine availability

Response by Pharmaceutical Management Agency to Daniel Richards on September 19, 2023.

Awaiting classification.

Kia ora Daniel Please find a response to your request attached to this email. Ngâ mihi, Katy Carlson ([1]she/her) | Government Se...

Information regarding medicinal cannabis prescriptions

Response by Pharmaceutical Management Agency to Mr McDonald on June 14, 2023.

Information not held.

Kia ora Mr McDonald, Please find a response to your request attached to this email. Kind regards, Gendi McFadyen| Government Services Advisor Te Pāt...

Estimating the number of people prescribed PrEP

Response by Pharmaceutical Management Agency to Bianca Sepulveda on June 11, 2021.

Successful.

Kia ora Bianca Please find attached a response to your recent request for information. Ngā mihi Melody Willis ([1]she/her) | Gove...

Trikafta Funding Announcement

Response by Pharmaceutical Management Agency to Phillip Hart on February 21, 2023.

Partially successful.

Tçnâ koe Phillip Further to our previous communications, we have now published [1]information about our communications approach for the Trikafta...

Correspondence between Pharmac and Draper Cormack re 2022-23-125; A1665003

Response by Pharmaceutical Management Agency to Harris Leigh on April 28, 2023.

Successful.

Tēnā koe Harris Please find a response to your request for information attached with this email. Ngā mihi, nā Melody Willis ([1]...

All emails from the Chief Executive, Director of Operations and communications staff in 2022 mentioning continuous glucose monitors

Response by Pharmaceutical Management Agency to Stefan Clausing on March 30, 2023.

Awaiting classification.

Kia ora Stefan, Please find a response to your request attached to this email. Kind regards Gendi McFadyen| Government Services Advisor Te Pātaka Wh...

Procurement process for Cormack Draper

Response by Pharmaceutical Management Agency to Harris Leigh on March 28, 2023.

Partially successful.

Tçnâ koe Harris Please find a response to your below request for information attached to this email. Ngâ mihi, nâ Melody Willis...

Funding for Ixekizumab

Response by Pharmaceutical Management Agency to Ms Faulkner on March 21, 2023.

Awaiting classification.

Kia ora Ms Faulkner, Please find a response to your request attached to this email. Kind regards, Gendi McFadyen| Government Services Advisor Te Pāt...

Rolling reviews of safety & efficacy of (non-mRNA gene therapy) COVID-19 treatments

Response by Pharmaceutical Management Agency to J Bruning on January 17, 2023.

Successful.

Kia ora Please find a response to your request for information attached with this email. Ngā mihi Melody Willis (she/her) | Government Services Adv...

Correspondence between Pharmac and NZMS

Request to Pharmaceutical Management Agency by D Smith. Annotated by Jai Ganesh on December 17, 2022.

Awaiting classification.

Sooo Medsafe knew that Ivermectin was a safe and effective treatment but because a pharmaceutical company didn't apply to push it out because it's not...

Communications regarding funding of Freestyle Libre monitors

Response by Pharmaceutical Management Agency to Harry Peterson on December 09, 2022.

Awaiting classification.

Kia ora please see attached 😊 Arihia Gray [1](she/her) | Policy advisor 9 December 2022 J Burning [email address] Tēnā koe J Burning Request...

Process and progress of approval for pediatric/under 5’s covid vaccines

Response by Pharmaceutical Management Agency to Scout Barbour-Evans on September 20, 2022.

Partially successful.

Kia ora Scout Please find attached a response to your request for official information. Ngā mihi OIA Services Team M[1]inistry of Health...

Ordering Moderna's Bivalent vaccine

Response by Pharmaceutical Management Agency to Athina Andonatou on October 13, 2022.

Successful.

Hi Athina, Please find a response to your request attached to this email. Kind regards, Gendi 13 October 2022 Athina Andonatou Via email: [FOI #205...

Cost of spending on Caresens Diabetes test kits

Response by Pharmaceutical Management Agency to Harry Peterson on August 16, 2022.

Long overdue.

Thank you for emailing Pharmac enquiries. * [1]View a list of all currently funded medicines (the Pharmaceutical Schedule) * [2]View the progress o...

Molnupiravir for Horses, Zebras & Donkeys - offspring born with no teeth & skull missing

Response by Pharmaceutical Management Agency to Micky Turner on January 24, 2022.

Successful.

Thank you for emailing Pharmac enquiries. * [1]View a list of all currently funded medicines (the Pharmaceutical Schedule) * [2]View the progress o...

FYI

More about this authority